Search results
Earnings call: SelectQuote sees growth in Medicare Advantage, raises outlook By Investing.com
Investing.com· 7 days agoSelectQuote, Inc. (SLQT) delivered a confident fiscal third-quarter earnings report, emphasizing...
HHS Final Section 1557 Nondiscrimination Regulations: Gender-Affirming Care and the Role of Carriers...
The National Law Review· 7 days agoIf Section 1557 applies to carriers and TPAs acting in an ASO capacity for self-funded group health...
Uber Caregiver: What to know about new service
FOX 8 Cleveland· 1 day agoUber is launching a new service that could be a gamechanger for families.
EXCLUSIVE: Uber has a new product designed to help caregivers. How does it work?
TODAY via Yahoo News· 22 hours agoUber is launching a new product called Uber Caregiver. How does it work? Here's what to know about...
Medicare statistics 2024
Consumer Affairs· 1 day agoGain insight into the Medicare program, including its history, structure, membership demographics, finances and future sustainability.
Suze Orman: Why Even Big Retirement Savers Are at Risk
GOBankingRates via Yahoo Finance· 4 days agoHaving a hefty retirement account is great, but that alone isn't enough. If you don't understand...
Comment: Turning 65? Here’s what to know about Medicare | HeraldNet.com
Everett Herald· 2 days agoWhether this milestone means retirement or not, these individuals need to make important choices about their health care. For many Washington residents, the transition from an employer-sponsored ...
Sage Health opens third Baltimore-area health center for seniors - Maryland Daily Record
The Daily Record· 1 day agoSage Health, a new value-based health care company that will serve seniors with high-performance...
Uber launches Uber Caregiver, targeting caregivers and those they assist
Supermarket News· 23 hours agoUber Health has launched Uber Caregiver, a new solution that targets caregivers. Beginning this...
Does Medicare Cover the RSV Vaccine?
US News Health· 3 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.